SCHEMBL925704

SCHEMBL925704

CCNSSC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3896192 0.97
SCHEMBL3322626 0.69
Ammonia Solution, Strong SCHEMBL19501699 0.67
SCHEMBL2156910 0.65
SCHEMBL19519266 0.63
Diethylamine SCHEMBL28176759 0.62
Fluoride SCHEMBL16266752 0.62 TP53 (0.33)
SCHEMBL1900698 0.59
SCHEMBL13538948 0.59
SCHEMBL33233 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2540320-A1 LEPTOMYCIN DERIVATIVES SANOFI (FR) 2013-01-02 EP disclosed
EP-2032172-B1 LEPTOMYCIN DERIVATIVES SANOFI SA (FR) 2012-06-06 EP disclosed
US-20110002947-A1 LEPTOMYCIN DERIVATIVES SANOFI-AVENTIS (FR) 2011-01-06 US disclosed
US-7816543-B2 Leptomycin derivatives SANOFI-AVENTIS (FR) 2010-10-19 US disclosed
US-20090182038-A1 Leptomycin Derivatives SANOFI-AVENTIS (FR) 2009-07-16 US disclosed
EP-2032172-A2 LEPTOMYCIN DERIVATIVES Sanofi-Aventis (FR) 2009-03-11 EP disclosed
WO-2007144709-A2 LEPTOMYCIN DERIVATIVES SANOFI-AVENTIS (FR) 2007-12-21 WO disclosed
EP-1864682-A1 Leptomycin derivatives Sanofi-Aventis (FR) 2007-12-12 EP disclosed
EP-0375422-B1 Composition and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine BEHRINGWERKE AG (DE) 1996-07-03 EP disclosed
US-5328828-A Immunoassay for amphetamines with antibodies for conjugation and enzymes SYNTEX (U.S.A.) INC. (US) 1994-07-12 US disclosed
US-5135863-A Immunoassay; drug abuse SYNTEX (U.S.A.) INC. (US) 1992-08-04 US disclosed
EP-0375422-A2 Composition and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine BEHRINGWERKE Aktiengesellschaft (DE) 1990-06-27 EP disclosed